Inc. (Nasdaq: IMGN), a biotechnology company that develops novel
anticancer therapeutics using its antibody-drug conjugate (ADC)
technology, today announced that the following presentation by Company
management at an upcoming investor conference will be webcast:
The webcast will be accessible live through the “Investor Information”
section of the Company’s website, www.immunogen.com ;
a replay will be available at the same location for approximately a week.
for ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences investment picks